{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:46:54Z","timestamp":1790419614298,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11910-019-1004-1","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T06:02:30Z","timestamp":1574661750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Stroke in the Young: a Global Update"],"prefix":"10.1007","volume":"19","author":[{"given":"Mausaminben Y.","family":"Hathidara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasu","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer M.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"key":"1004_CR1","unstructured":"World Health Organization. Health statistics and information systems. 2019; Available from: https:\/\/www.who.int\/healthinfo\/global_burden_disease\/en\/."},{"issue":"5","key":"1004_CR2","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1016\/S2214-109X(13)70089-5","volume":"1","author":"RV Krishnamurthi","year":"2013","unstructured":"Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2013;1(5):e259\u201381.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"1004_CR3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000441098","volume":"45","author":"RV Krishnamurthi","year":"2015","unstructured":"Krishnamurthi RV, Moran AE, Feigin VL, Barker-Collo S, Norrving B, Mensah GA, et al. Stroke prevalence, mortality and disability-adjusted life years in adults aged 20-64 years in 1990-2013: data from the Global Burden of Disease 2013 Study. Neuroepidemiology. 2015;45(3):190\u2013202.","journal-title":"Neuroepidemiology"},{"issue":"1","key":"1004_CR4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00415-015-7977-z","volume":"263","author":"BG Simonetti","year":"2016","unstructured":"Simonetti BG, Mono ML, Huynh-Do U, Michel P, Odier C, Sztajzel R, et al. Erratum to: risk factors, aetiology and outcome of ischaemic stroke in young adults: the Swiss Young Stroke Study (SYSS). J Neurol. 2016;263(1):199\u2013200.","journal-title":"J Neurol"},{"issue":"6","key":"1004_CR5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/jamaneurol.2017.0020","volume":"74","author":"MG George","year":"2017","unstructured":"George MG, Tong X, Bowman BA. Prevalence of cardiovascular risk factors and strokes in younger adults. JAMA Neurol. 2017;74(6):695\u2013703.","journal-title":"JAMA Neurol"},{"issue":"11","key":"1004_CR6","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1468-1331.2010.03073.x","volume":"17","author":"AJ Metso","year":"2010","unstructured":"Metso AJ, Metso TM, Putaala J, Tatlisumak T. Stroke in young adults: every saga has a beginning. Eur J Neurol. 2010;17(11):1317.","journal-title":"Eur J Neurol"},{"key":"1004_CR7","first-page":"535672","volume":"2011","author":"C Marini","year":"2010","unstructured":"Marini C, Russo T, Felzani G. Incidence of stroke in young adults: a review. Stroke Res Treat. 2010;2011:535672.","journal-title":"Stroke Res Treat"},{"issue":"2","key":"1004_CR8","first-page":"515","volume":"37","author":"D Smajlovic","year":"2013","unstructured":"Smajlovic D, et al. Characteristics of stroke in young adults in Tuzla Canton, Bosnia and Herzegovina. Coll Antropol. 2013;37(2):515\u20139.","journal-title":"Coll Antropol"},{"issue":"9913","key":"1004_CR9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(13)61953-4","volume":"383","author":"VL Feigin","year":"2014","unstructured":"Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245\u201354.","journal-title":"Lancet"},{"issue":"6","key":"1004_CR10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jamaneurol.2017.0161","volume":"74","author":"JF Burke","year":"2017","unstructured":"Burke JF, Skolarus LE. Are more young people having strokes?-a simple question with an uncertain answer. JAMA Neurol. 2017;74(6):639\u201341.","journal-title":"JAMA Neurol"},{"issue":"12","key":"1004_CR11","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1161\/01.STR.0000038988.64376.3A","volume":"33","author":"BS Jacobs","year":"2002","unstructured":"Jacobs BS, Boden-Albala B, Lin IF, Sacco RL. Stroke in the young in the northern Manhattan stroke study. Stroke. 2002;33(12):2789\u201393.","journal-title":"Stroke"},{"issue":"12 Suppl","key":"1004_CR12","first-page":"I13\u20135","volume":"24","author":"SJ Kittner","year":"1993","unstructured":"Kittner SJ, et al. Black-white differences in stroke risk among young adults. Stroke. 1993;24(12 Suppl):I13\u20135 discussion I20\u20131.","journal-title":"Stroke"},{"issue":"2","key":"1004_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11239-005-3201-9","volume":"20","author":"JY Chong","year":"2005","unstructured":"Chong JY, Sacco RL. Epidemiology of stroke in young adults: race\/ethnic differences. J Thromb Thrombolysis. 2005;20(2):77\u201383.","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"1004_CR14","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1161\/01.STR.0000021409.16314.16","volume":"33","author":"TH Lee","year":"2002","unstructured":"Lee TH, Hsu WC, Chen CJ, Chen ST. Etiologic study of young ischemic stroke in Taiwan. Stroke. 2002;33(8):1950\u20135.","journal-title":"Stroke"},{"issue":"1","key":"1004_CR15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.STR.32.1.52","volume":"32","author":"C Marini","year":"2001","unstructured":"Marini C, Totaro R, de Santis F, Ciancarelli I, Baldassarre M, Carolei A. Stroke in young adults in the community-based L\u2019Aquila registry: incidence and prognosis. Stroke. 2001;32(1):52\u20136.","journal-title":"Stroke"},{"issue":"11","key":"1004_CR16","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1161\/01.STR.26.11.1995","volume":"26","author":"AI Qureshi","year":"1995","unstructured":"Qureshi AI, Safdar K, Patel M, Janssen RS, Frankel MR. Stroke in young black patients. Risk factors, subtypes, and prognosis. Stroke. 1995;26(11):1995\u20138.","journal-title":"Stroke"},{"issue":"3","key":"1004_CR17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/01.STR.30.3.537","volume":"30","author":"JL Ruiz-Sandoval","year":"1999","unstructured":"Ruiz-Sandoval JL, Cantu C, Barinagarrementeria F. Intracerebral hemorrhage in young people: analysis of risk factors, location, causes, and prognosis. Stroke. 1999;30(3):537\u201341.","journal-title":"Stroke"},{"issue":"11","key":"1004_CR18","first-page":"1246","volume":"43","author":"W Li","year":"2018","unstructured":"Li W, et al. Etiologies and risk factors for young people with intracerebral hemorrhage. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43(11):1246\u201350.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"1004_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35\u201341.","journal-title":"Stroke"},{"issue":"4","key":"1004_CR20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.50.4.890","volume":"50","author":"SJ Kittner","year":"1998","unstructured":"Kittner SJ, Stern BJ, Wozniak M, Buchholz DW, Earley CJ, Feeser BR, et al. Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Neurology. 1998;50(4):890\u20134.","journal-title":"Neurology"},{"issue":"4","key":"1004_CR21","first-page":"239","volume":"16","author":"T Cardoso","year":"2003","unstructured":"Cardoso T, Fonseca T, Costa M. Stroke in young adults. Acta Medica Port. 2003;16(4):239\u201344.","journal-title":"Acta Medica Port"},{"issue":"4","key":"1004_CR22","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/STROKEAHA.108.529883","volume":"40","author":"J Putaala","year":"2009","unstructured":"Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009;40(4):1195\u2013203.","journal-title":"Stroke"},{"issue":"3\u20134","key":"1004_CR23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000455093","volume":"77","author":"F Li","year":"2017","unstructured":"\u2022 Li F, et al. Ischemic stroke in young adults of Northern China: characteristics and risk factors for recurrence. Eur Neurol. 2017;77(3\u20134):115\u201322 In 1395 patients, the most common causes of stroke were large vessel atherosclerosis and small vessel occlusion, followed by cardio-embolism, while a higher NIHSS score was associated with stroke recurrence.","journal-title":"Eur Neurol"},{"issue":"2","key":"1004_CR24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/NRL.0000000000000110","volume":"22","author":"VV Montanaro","year":"2017","unstructured":"\u2022 Montanaro VV, et al. Ischemic stroke in young adults: profile of SARAH Hospital Brasilia From 2008 to 2012. Neurologist. 2017;22(2):61\u20133 Retrospective study of young ischemic stroke patients admitted to a neurological rehabilitation program in Brazil. There was a significant association between thrombophilia and patent foramen ovale, but no significant association was found between thrombophilia and arterial dissection.","journal-title":"Neurologist"},{"issue":"7","key":"1004_CR25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1474-4422(09)70084-5","volume":"8","author":"S Debette","year":"2009","unstructured":"Debette S, Leys D. Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol. 2009;8(7):668\u201378.","journal-title":"Lancet Neurol"},{"issue":"7","key":"1004_CR26","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1161\/01.STR.0000169919.73219.30","volume":"36","author":"SM Rubinstein","year":"2005","unstructured":"Rubinstein SM, Peerdeman SM, van Tulder MW, Riphagen I, Haldeman S. A systematic review of the risk factors for cervical artery dissection. Stroke. 2005;36(7):1575\u201380.","journal-title":"Stroke"},{"issue":"6","key":"1004_CR27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jamaneurol.2019.0072","volume":"76","author":"HS Markus","year":"2019","unstructured":"\u2022\u2022 Markus HS, et al. Antiplatelet therapy vs anticoagulation therapy in cervical artery dissection: the Cervical Artery Dissection in Stroke Study (CADISS) randomized clinical trial final results. JAMA Neurol. 2019;76(6):657\u201364 The authors concluded non-inferiority of anti-platelets over anti-coagulation for secondary stroke prevention in the management of cervical arterial dissection patients.","journal-title":"JAMA Neurol"},{"issue":"4","key":"1004_CR28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(15)70018-9","volume":"14","author":"HS Markus","year":"2015","unstructured":"Markus HS, et al. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial. Lancet Neurol. 2015;14(4):361\u20137.","journal-title":"Lancet Neurol"},{"issue":"7","key":"1004_CR29","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/STROKEAHA.109.547828","volume":"40","author":"AA Alsheikh-Ali","year":"2009","unstructured":"Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009;40(7):2349\u201355.","journal-title":"Stroke"},{"issue":"8","key":"1004_CR30","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00415-018-8865-0","volume":"265","author":"B Miranda","year":"2018","unstructured":"Miranda B, Fonseca AC, Ferro JM. Patent foramen ovale and stroke. J Neurol. 2018;265(8):1943\u20139.","journal-title":"J Neurol"},{"key":"1004_CR31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1745-6215-12-185","volume":"12","author":"DM Kent","year":"2011","unstructured":"Kent DM, Thaler DE. The Risk of Paradoxical Embolism (RoPE) Study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke. Trials. 2011;12:185.","journal-title":"Trials"},{"issue":"12","key":"1004_CR32","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","volume":"368","author":"JD Carroll","year":"2013","unstructured":"Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368(12):1092\u2013100.","journal-title":"N Engl J Med"},{"issue":"11","key":"1004_CR33","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","volume":"366","author":"AJ Furlan","year":"2012","unstructured":"Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991\u20139.","journal-title":"N Engl J Med"},{"issue":"12","key":"1004_CR34","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","volume":"368","author":"B Meier","year":"2013","unstructured":"Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368(12):1083\u201391.","journal-title":"N Engl J Med"},{"issue":"2","key":"1004_CR35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2013.08.058","volume":"169","author":"G Ntaios","year":"2013","unstructured":"Ntaios G, Papavasileiou V, Makaritsis K, Michel P. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis. Int J Cardiol. 2013;169(2):101\u20135.","journal-title":"Int J Cardiol"},{"issue":"7","key":"1004_CR36","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2014;45(7):2160\u2013236.","journal-title":"Stroke"},{"issue":"11","key":"1004_CR37","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","volume":"377","author":"JL Mas","year":"2017","unstructured":"\u2022\u2022 Mas JL, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377(11):1011\u201321 The stroke recurrence rate was lower in patients assigned to PFO closure combined with anti-platelet therapy vs. in those assigned to anti-platelet therapy alone among patients with recent cryptogenic stroke attributed to PFO with an associated atrial septal aneurysm or large interatrial shunt.","journal-title":"N Engl J Med"},{"issue":"11","key":"1004_CR38","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","volume":"377","author":"JL Saver","year":"2017","unstructured":"\u2022\u2022 Saver JL, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377(11):1022\u201332 During extended follow-up of 980 patients with median duration 5.9\u00a0years, PFO closure was associated with a lower recurrent ischemic stroke rate vs. medical therapy alone (aspirin, clopidogrel, aspirin combined with extended-release dipyridamole, or warfarin) among adults with cryptogenic ischemic stroke.","journal-title":"N Engl J Med"},{"issue":"11","key":"1004_CR39","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"L Sondergaard","year":"2017","unstructured":"\u2022\u2022 Sondergaard L, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377(11):1033\u201342 Among patients with cryptogenic stroke attributable to PFO, the subsequent ischemic stroke risk was lower among patients receiving PFO closure combined with anti-platelet therapy vs. among those assigned to anti-platelet therapy alone.","journal-title":"N Engl J Med"},{"issue":"8","key":"1004_CR40","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/STROKEAHA.110.581256","volume":"41","author":"AG Hamedani","year":"2010","unstructured":"Hamedani AG, Cole JW, Mitchell BD, Kittner SJ. Meta-analysis of factor V Leiden and ischemic stroke in young adults: the importance of case ascertainment. Stroke. 2010;41(8):1599\u2013603.","journal-title":"Stroke"},{"issue":"10","key":"1004_CR41","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1182\/blood.V91.10.3562","volume":"91","author":"V De Stefano","year":"1998","unstructured":"De Stefano V, et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood. 1998;91(10):3562\u20135.","journal-title":"Blood"},{"issue":"11","key":"1004_CR42","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.1538-7836.2009.03577.x","volume":"7","author":"AR Folsom","year":"2009","unstructured":"Folsom AR, et al. Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. J Thromb Haemost. 2009;7(11):1774\u20138.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"1004_CR43","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.006","volume":"28","author":"SS Omran","year":"2019","unstructured":"Omran SS, Lerario MP, Gialdini G, Merkler AE, Moya A, Chen ML, et al. Clinical impact of thrombophilia screening in young adults with ischemic stroke. J Stroke Cerebrovasc Dis. 2019;28(4):882\u20139.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"6","key":"1004_CR44","volume":"9","author":"Z Shi","year":"2019","unstructured":"Shi Z, et al. Contribution of dehydration to END in acute ischemic stroke not mediated via coagulation activation. Brain Behav. 2019;9(6):e01301.","journal-title":"Brain Behav"},{"issue":"Suppl 1","key":"1004_CR45","first-page":"S15","volume":"48","author":"Z Alfirevic","year":"2010","unstructured":"Alfirevic Z, Alfirevic I. Hypercoagulable state, pathophysiology, classification and epidemiology. Clin Chem Lab Med. 2010;48(Suppl 1):S15\u201326.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"1004_CR46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/QCO.0000000000000547","volume":"32","author":"DV Jillella","year":"2019","unstructured":"Jillella DV, Wisco DR. Infectious causes of stroke. Curr Opin Infect Dis. 2019;32(3):285\u201392.","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"1004_CR47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11910-012-0325-0","volume":"13","author":"AC Fonseca","year":"2013","unstructured":"Fonseca AC, Ferro JM. Drug abuse and stroke. Curr Neurol Neurosci Rep. 2013;13(2):325.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"13","key":"1004_CR48","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/CIRCULATIONAHA.116.025778","volume":"135","author":"CJ Bright","year":"2017","unstructured":"\u2022 Bright CJ, et al. Risk of cerebrovascular events in 178 962 five-year survivors of cancer diagnosed at 15 to 39 years of age: The TYACSS (Teenage and Young Adult Cancer Survivor Study). Circulation. 2017;135(13):1194\u2013210 Large population-based study conducted in England that found that survivors of a central nervous system tumor, head and neck tumor, and leukemia are at particular risk of hospitalization for a cerebrovascular event.","journal-title":"Circulation"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-019-1004-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-019-1004-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-019-1004-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:24:37Z","timestamp":1659090277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-019-1004-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1004"],"URL":"https:\/\/doi.org\/10.1007\/s11910-019-1004-1","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"25 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Mausaminben Y. Hathidara, Vasu Saini, and Amer M. Malik each declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"91"}}